Besides HNSCC, upregulation of cytolytic activity significantly correlated with EP300 mutation in esophageal squamous cell carcinomas, gastric carcinomas and prostate carcinomas (Fig. 3A). The gene discussed is EP300; the disease is gastric carcinoma.